Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,240,624 papers from all fields of science
Search
Sign In
Create Free Account
Cytidine Deaminase Inhibitor
Any substance that inhibits cytidine deaminase, an enzyme that scavenges exogenous and endogenous cytidine and 2'-deoxycytidine for UMP synthesis…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
The combination of the anti-neoplastic agent and a cytidine deaminase inhibitor of Shichijinbesu, and its use in the treatment of cancer
ヴァール,マーク
,
デュヴァル,ブリジット
,
ハミルトン,グレゴリー
,
フェラリス,デイナ
,
ベリャコフ,セルゲイ
2010
Corpus ID: 89864863
Compounds used to inhibit deamination enzyme which is responsible for the inactivation of therapeutic compounds, and methods of…
Expand
2006
2006
Gemcitabine (G) plamsa and intracellular pharmacokinetics in E6201: Greater metabolite levels using fixed dosing rate (FDR) delivery.
L. Liebes
,
D. Levy
,
+6 authors
H. Hochster
Journal of Clinical Oncology
2006
Corpus ID: 31903978
2024 Background: Gemcitabine (G) is an antimetabolite which requires activation by the rate-limiting enzyme dCK to its active…
Expand
1998
1998
Accumulation of arabinosyluracil 5'-triphosphate during arabinosylcytosine therapy in circulating blasts of patients with acute myelogenous leukemia.
V. Gandhi
,
Y. Z. Xu
,
E. Estey
Clinical Cancer Research
1998
Corpus ID: 24568046
Arabinosylcytosine (ara-C) is the most effective nucleoside analogue for treatment of acute myelogenous leukemia. The…
Expand
1995
1995
Characterization of a multidrug resistant human erythroleukemia cell line (K562) exhibiting spontaneous resistance to 1-beta-D-arabinofuranosylcytosine.
S. Grant
,
A. Turner
,
P. Nelms
,
S. Yanovich
Leukemia
1995
Corpus ID: 24883155
We have assessed the response of a previously characterized multidrug resistant (MDR) human erythroleukemia cell line (K562R) to…
Expand
1986
1986
Deoxycytidine stimulates the in vitro growth of normal CFU-GM and reverses the negative regulatory effects of acidic isoferritin and prostaglandin E1.
K. Bhalla
,
J. Cole
,
+4 authors
S. Grant
Blood
1986
Corpus ID: 8868471
We have examined the effect of supraphysiologic concentrations of the naturally occurring nucleoside deoxycytidine (dCyd) on the…
Expand
1984
1984
Reversal of deamination-related cytotoxicity of 5-methyl-2'-deoxycytidine by tetrahydrouridine in human leukemia cells.
A. Jekunen
,
J. Vilpo
Journal of the National Cancer Institute
1984
Corpus ID: 33730543
The present experiments were conducted to test the effects of the potent cytidine deaminase inhibitor tetrahydrouridine (THU) on…
Expand
1979
1979
Effect of tetrahydrouridine on the action of 1-beta-D-arabinofuranosylcytosine in synchronized cultures of normal rat kidney cells.
C. Wan
,
T. W. Mak
Cancer Research
1979
Corpus ID: 38658226
Tetrahydrouridine (THU) is a reduced pyrimidine nucleoside and has been found to be a potent cytidine deaminase inhibitor. We…
Expand
Review
1978
Review
1978
ARA-C analogs.
P. Alberto
Antibiotics and Chemotherapy
1978
Corpus ID: 2296977
Ara-C, a phase-specific antitumor agent, is rapidly deactivated by the enzyme cytidine deaminase. A prolongation of the…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE